Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balzarini

Showing results (1-10 of 1,584) with videos related to

Pageof 159
Sort By:
Pharmacology & Therapeutics|September 29, 2000
Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitorsJ Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives]J Balzarini
The Lancet. Infectious Diseases|October 29, 2005
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIVJan Balzarini
Nature Reviews. Microbiology|July 17, 2007
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapyJan Balzarini
Current Topics in Medicinal Chemistry|May 12, 2004
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1J Balzarini
Pharmacy World & Science : PWS|April 15, 1994
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesJ Balzarini
Antiviral Chemistry & Chemotherapy|March 16, 2007
Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?Jan Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1995
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitorsJ Balzarini
Current Opinion in HIV and AIDS|April 18, 2009
Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120Jan Balzarini
Methods in Molecular Medicine|February 19, 2011
Evaluation of Compounds Against Recombinant HIV Reverse TranscriptaseJ Balzarini
Pageof 159

Showing results (1-10 of 1,584) with videos related to

Sort By:
Pageof 159
Pharmacology & Therapeutics|September 29, 2000
Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitorsJ Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives]J Balzarini
The Lancet. Infectious Diseases|October 29, 2005
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIVJan Balzarini
Nature Reviews. Microbiology|July 17, 2007
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapyJan Balzarini
Current Topics in Medicinal Chemistry|May 12, 2004
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1J Balzarini
Pharmacy World & Science : PWS|April 15, 1994
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesJ Balzarini
Antiviral Chemistry & Chemotherapy|March 16, 2007
Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?Jan Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1995
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitorsJ Balzarini
Current Opinion in HIV and AIDS|April 18, 2009
Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120Jan Balzarini
Methods in Molecular Medicine|February 19, 2011
Evaluation of Compounds Against Recombinant HIV Reverse TranscriptaseJ Balzarini
Pageof 159